Bloomberg: AstraZeneca Wants To Hold Another Vaccine Trial

Watch VideoAstraZeneca's CEO says the company needs to conduct another global trial for its vaccine. That's according to a report from Bloomberg. 

AstraZeneca initially said its vaccine showed 62 percent effectiveness when taken as a full two-dose regimen. 

It also said the vaccine was up to 90 percent effective when...